Serum CA125 level as predictors of the efficacy of olaparib maintenance therapy for platinum-sensitive relapsed ovarian cancer.

Fumio AsanoMai MomomuraTohru MorisadaKana TsushimaYumi HarunaHiromi ShibuyaHironori MatsumotoYoichi Kobayashi

Published in: The journal of obstetrics and gynaecology research (2023)

Serum CA125 levels at olaparib initiation in patients with platinum-sensitive relapsed ovarian cancer may predict PFS as an effect of maintenance therapy using olaparib to treat recurrent disease.

Keyphrases

acute lymphoblastic leukemia
acute myeloid leukemia
multiple myeloma
diffuse large b cell lymphoma
hodgkin lymphoma
protein kinase
bone marrow
smoking cessation